Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO₂ nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine

References

• SinkovicsJGHorvathJCNewcastle disease virus (NDV): brief history of its oncolytic strainsJ Clin Virol200016111510680736
   PubMed Web of Science ®Google Scholar
• AlexanderDJAldousEWFullerCMThe long view: a selective review of 40 years of Newcastle disease researchAvian Pathol201241432933522834545
   PubMed Web of Science ®Google Scholar
• TsengLPChiouCJDengMCEvaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunityJ Biomed Mater Res B Appl Biomater200991262162519582853
   PubMedGoogle Scholar
• MillerPJKingDJAfonsoCLSuarezDLAntigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challengeVaccine200725417238724617719150
   PubMed Web of Science ®Google Scholar
• MeulemansGGonzeMCarlierMCPetitPBurnyALongLProtective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle diseaseAvian Pathol198615476176818766577
   PubMed Web of Science ®Google Scholar
• WangRDoolanDLLeTPInduction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccineScience199828253884764809774275
   PubMed Web of Science ®Google Scholar
• XuKLingZYSunLBroad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virusViral Immunol2011241455621319978
   PubMed Web of Science ®Google Scholar
• HallengärdDHallerBKPeterssonSIncreased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activityVaccine201129483984821109032
   PubMed Web of Science ®Google Scholar
• AbbasAODonovanMDSalemAKFormulating poly(lactide-co-glycolide) particles for plasmid DNA deliveryJ Pharm Sci20089772448246117918737
   PubMed Web of Science ®Google Scholar
• IntraJSalemAKFabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in non-viral gene deliveryJ Pharm Sci201099136838419670295
   PubMed Web of Science ®Google Scholar
• WuHDennisVAPillaiSRSinghSRRSV fusion (F) protein DNA vaccine provides partial protection against viral infectionVirus Res20091451394719540885
   PubMed Web of Science ®Google Scholar
• WangTUpponiJRTorchilinVPDesign of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategiesInt J Pharm2012427132021798324
   PubMed Web of Science ®Google Scholar
• KimYCSongJMLipatovASIncreased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patchEur J Pharm Biopharm201281223924722504442
   PubMed Web of Science ®Google Scholar
• ConeseMAscenzioniFBoydACGene and cell therapy for cystic fibrosis: from bench to bedsideJ Cyst Fibros201110Suppl 2S114S12821658631
   PubMedGoogle Scholar
• FowlerVRobinsonLBankowskiBA DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth diseaseAntiviral Res2012941253422330893
   PubMed Web of Science ®Google Scholar
• ManojSBabiukLAvan Drunen Littel-van den HurkSApproaches to enhance the efficacy of DNA vaccinesCrit Rev Clin Lab Sci200441113915077722
   PubMed Web of Science ®Google Scholar
• SunJLiDHaoYPosttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacyDNA Cell Biol200928523324019388846
   PubMed Web of Science ®Google Scholar
• GerdtsVMutwiriGRichardsJvan Drunen Littel-van den HurkSPotterAACarrier molecules for use in veterinary vaccinesVaccine201331459660223219438
   PubMed Web of Science ®Google Scholar
• BottiniMD’AnnibaleFMagriniAQuantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytesInt J Nanomedicine20072222723317722550
   PubMed Web of Science ®Google Scholar
• GerionDHerbergJBokRParamagnetic silica-coated nanocrystals as an advanced MRI contrast agentJ Phys Chem C Nanomater Interfaces2007111341254212551
   Web of Science ®Google Scholar
• GrafCDembskiSHofmannARühlEA general method for the controlled embedding of nanoparticles in silica colloidsLangmuir200622135604561016768483
   PubMed Web of Science ®Google Scholar
• Meseguer-OlmoLRos-NicolásMVicente-OrtegaVA bioactive sol-gel glass implant for in vivo gentamicin release. Experimental model in RabbitJ Orthop Res200624345446016450408
   PubMed Web of Science ®Google Scholar
• RadinSEl-BassyouniGVresilovicEJSchepersEDucheynePIn vivo tissue response to resorbable silica xerogels as controlled-release materialsBiomaterials20052691043105215369693
   PubMed Web of Science ®Google Scholar
• TeoliDParisiLRealdonNGuglielmiMRosatoAMorpurgoMWet sol-gel derived silica for controlled release of proteinsJ Control Release2006116329530317097181
   PubMed Web of Science ®Google Scholar
• DormerKSeeneyCLewellingKLianGGibsonDJohnsonMEpithelial internalization of superparamagnetic nanoparticles and response to external magnetic fieldBiomaterials200526142061207215576180
   PubMed Web of Science ®Google Scholar
• ArrueboMGalánMNavascuésNDevelopment of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applicationsChem Mater200618719111919
   Web of Science ®Google Scholar
• ZhaoWGuJZhangLChenHShiJFabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structureJ Am Chem Soc2005127258916891715969545
   PubMed Web of Science ®Google Scholar
• AlloucheJBoissièreMHélaryCLivageJCoradinTBiomimetic core–shell gelatine/silica nanoparticles: a new example of biopolymer-based nanocompositesJ Mater Chem2006163031203125
   Web of Science ®Google Scholar
• HuoQLiuJWangLQJiangYLambertTNFangEA new class of silica cross-linked micellar core-shell nanoparticlesJ Am Chem Soc2006128196447645316683810
   PubMed Web of Science ®Google Scholar
• TynerKMSchiffmanSRGiannelisEPNanobiohybrids as delivery vehicles for camptothecinJ Control Release200495350151415023461
   PubMed Web of Science ®Google Scholar
• ZhaoJFuXZhangSHouWWater dispersible avermectin-layered double hydroxide nanocomposites modified with sodium dodecyl sulfateAppl Clay Sci2011514460466
   Web of Science ®Google Scholar
• YuanYShiWA novel LDH nanofiller intercalated by silsesquioxane for preparing organic/inorganic hybrid compositesAppl Clay Sci201267–688390
   Web of Science ®Google Scholar
• KangHShuYLiZAn effect of alginate on the stability of LDH nanosheets in aqueous solution and preparation of alginate/LDH nanocompositesCarbohydr Polym201410015816524188850
   PubMed Web of Science ®Google Scholar
• ZengWShiXGaoHOptimization of codon usage of F gene enhanced efficacy of Newcastle disease virus DNA vaccineChin J Anim Infecti Dis200917816
   Google Scholar
• SambrookJRussellDWMolecular Cloning: A Laboratory ManualCold Spring HarborCold Spring Harbor Laboratory Press2001
   Google Scholar
• ZhaoKZhangYZhangXPreparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticlesInt J Nanomedicine2014938940224426783
   PubMed Web of Science ®Google Scholar
• XuYDuYHuangRGaoLPreparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrierBiomaterials200324275015502214559015
   PubMed Web of Science ®Google Scholar
• AksungurPSungurAUnalSIskitABSquierCASenelSChitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studiesJ Control Release200498226927915262418
   PubMed Web of Science ®Google Scholar
• ZhaoFWuYZhangXEnhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2Hum Vaccin20117101083108921941092
   PubMed Web of Science ®Google Scholar
• KapczynskiDRKingDJProtection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreakVaccine200523263424343315837366
   PubMed Web of Science ®Google Scholar
• MillerPJEstevezCYuQSuarezDLKingDJComparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant virusesAvian Dis2009531394919432002
   PubMed Web of Science ®Google Scholar
• van BovenMBoumaAFabriTHKatsmaEHartogLKochGHerd immunity to Newcastle disease virus in poultry by vaccinationAvian Pathol20083711518202943
   PubMed Web of Science ®Google Scholar
• GurunathanSKlinmanDMSederRADNA vaccines: immunology, application, and optimization*Annu Rev Immunol20001892797410837079
   PubMed Web of Science ®Google Scholar
• BorgesOLebreFBentoDBorchardGJungingerHEMucosal vaccines: recent progress in understanding the natural barriersPharm Res201027221122319953309
   PubMed Web of Science ®Google Scholar
• JilekSMerkleHPWalterEDNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cellsAdv Drug Deliv Rev200557337739015560947
   PubMed Web of Science ®Google Scholar
• Waeckerle-MenYGroettrupMPLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccinesAdv Drug Deliv Rev200557347548215560953
   PubMed Web of Science ®Google Scholar
• ZhaoKLiWHuangTPreparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticlesPloS One2013812e8264824386106
   PubMed Web of Science ®Google Scholar
• WangLChenDA one-pot approach to the preparation of silver-PMMA “shell-core” nanocompositeColloid Polym Sci20062844449454
   Web of Science ®Google Scholar
• LiuHYeFCaoHJiGLeeJYYangJA core-shell templated approach to the nanocomposites of silver sulfide and noble metal nanoparticles with hollow/cage-bell structuresNanoscale20135156901690723783584
   PubMed Web of Science ®Google Scholar
• BoyogluSVigKPillaiSEnhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virusNanomedicine20095446347219341819
   PubMed Web of Science ®Google Scholar
• HuYJiangXDingYGeHYuanYYangCSynthesis and characterization of chitosan-poly(acrylic acid) nanoparticlesBiomaterials200223153193320112102191
   PubMed Web of Science ®Google Scholar
• GuptaPNKhatriKGoyalAKMishraNVyasSPM-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis BJ Drug Target2007151070171318041638
   PubMed Web of Science ®Google Scholar
• UgwokeMIAguRUVerbekeNKingetRNasal mucoadhesive drug delivery: background, applications, trends and future perspectivesAdv Drug Deliv Rev200557111640166516182408
   PubMed Web of Science ®Google Scholar
• XuJDaiWWangZChenBLiZFanXIntranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniaeClin Vaccine Immunol2011181758121047997
   PubMed Web of Science ®Google Scholar
• CrippsAWKydJMComparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumoniaVaccine200725132471247717110001
   PubMed Web of Science ®Google Scholar
• RussellPHDwivediPNDavisonTFThe effects of cyclosporin A and cyclophosphamide on the populations of B and T cells and virus in the Harderian gland of chickens vaccinated with the Hitchner B1 strain of Newcastle disease virusVet Immunol Immunopathol1997601–21711859533275
   PubMed Web of Science ®Google Scholar
• ReynoldsDLMaraqaADProtective immunity against Newcastle disease: the role of cell-mediated immunityAvian Dis200044114515410737655
   PubMed Web of Science ®Google Scholar